Literature DB >> 6097264

Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).

V Teetz, R Geiger, R Henning, H Urbach.   

Abstract

The convergent, diastereoselective synthesis of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe acid (Hoe 498), a new ACE-inhibitor with improved bioavailability and pharmacokinetics, is described.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097264

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  2 in total

1.  Hypothesized and found mechanisms for potentiation of bradykinin actions.

Authors:  Sylvia Mueller; Inge Paegelow; Siegmund Reissmann
Journal:  Signal Transduct       Date:  2006-01-17

2.  Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9alpha.

Authors:  Sylvia Mueller; Rita Gothe; Wolf-Dieter Siems; Gabriele Vietinghoff; Inge Paegelow; Siegmund Reissmann
Journal:  Peptides       Date:  2005-04-25       Impact factor: 3.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.